The Latest
-
Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit
The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.
-
Intuitive lowers profit margin forecast due to tariff pressure
CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend timelines for robot purchases.
-
Field Medical raises $40M for PFA in ventricular tachycardia
Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart rhythm disorder.
-
Trump tariffs
Who are the United States’ top trading partners?
Explore how over 200 countries’ imports, exports and trade balances with the U.S. last year stack up in this sortable chart.
-
Deep Dive // HHS overhaul
HHS layoffs may be illegal, legal experts say
The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
-
FDA issues early alert for BD catheters due to leaks
BD recalled certain intravascular catheters tied to reports of 10 serious injuries after finding an increase in cracks from “material fatigue.”
-
Dr. Oz sworn in as CMS administrator
During a ceremony at the Oval Office, Mehmet Oz said he would focus on reducing chronic disease, “modernizing” Medicare and Medicaid, and targeting fraud, waste and abuse in government insurance offerings.
-
Medtronic gets FDA approval to use Simplera Sync glucose sensor with insulin pumps
The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s diabetes business.
-
Precision Neuroscience receives FDA clearance for brain implant
The electrode array, which can be implanted for 30 days to map brain activity, is a component of Precision Neuroscience’s planned brain-computer interface system.
-
Intuitive, Boston Scientific and Edwards next up in medtech earnings
Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and competitive dynamics in key markets.
-
HHS overhaul
FDA cuts outlined in draft HHS budget
The draft budget would slash FDA’s budget authority, if approved by Congress.
-
Makary seeks to limit industry’s role in FDA advisory panels
Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as industry representatives on advisory committees.
Updated April 18, 2025 -
Retrieved from Ceribell on April 17, 2025
Ceribell wins FDA nod for algorithm to detect pediatric seizures
The clearance adds another feature for Ceribell to leverage as it tries to persuade hospitals to switch from conventional EEG systems.
-
Illinois, Minnesota join FTC challenge against $627M Surmodics buyout
The Illinois attorney general said the deal represents a “troubling trend of wealthy investors attempting to limit competition and innovation.”
-
Illumina, Tempus AI partner to drive genomic testing beyond cancer
The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing across all major diseases.
-
HHS overhaul
Budget draft outlines Trump’s plan to slash federal health programs
An OMB document proposes to cut the HHS budget by roughly one-third as well as eliminate several divisions and programs.